FranceFrance

BioAlliance Pharma’s launches Oravig in US market

25.08.2010

Paris – French public biotech company BioAlliance Pharma SA has announced the launch of Oravig (marketed as Loramyc in Europe) in the United States by its partner, Strativa Pharmaceuticals, a division of Par Pharmaceutical Companies, Inc. The treatment of oropharyngeal candidiasis in adults was greenlighted by the FDA this April. Bioalliance pharma said it expects significant revenues due to its partner’s strong US salesforce.

FranceFrance

17.02.2011

Paris/Cambridge (Mass.) – French pharma giant Sanofi-Aventis is set to take-over US biotech specialist Genzyme in a $20.1bn deal, the biggest corporate acquisition worldwide so far this year and the second-largest in the history...

FranceFrance

06.02.2011

Paris – A recently released study provides evidence that there is no reason to believe that omega fatty acids or B vitamins can protect you from severe cardiovascular disease (BMJ, doi: 10.1136/bmj.c6273.). A research group...

FranceFrance

06.02.2011

Nantes – The Nantes University Hospital Institute, also called the “European Center for Transplantation Sciences and Immunotherapy” (TSI-IHU), is commissioning new biomanufacturing capacities. Last year at the site, Atlantic Bio...

FranceFrance

31.01.2011

Bordeaux – A French-Spanish research team has determined that malnutrition with omega-3 fatty acids has deleterious consequences on synaptic functions and emotional behaviours in mice (Nature Neuroscience,...

FranceFrance

04.11.2010

Toulouse – Biopharmaceutical company Cerenis Therapeutics S.A., which is developing drugs based on high density lipoprotein (HDL) to treat cardiovascular diseases, has raised a further a10m in a second close of its third round of...

Displaying results 41 to 50 out of 268

< Previous 41-50 Next >

© 2007-2015 BIOCOM

http://www.european-biotechnology-news.com/nc/news/messages-archive/archive-france/browse/4/article/bioalliance-pharmas-launches-oravig-in-us-market.html

Video

All videos

Product of the week

Products

Events

All Events

Partner-Events

Planegg/Martinsried

1st Munich Biotech Pitch

Berlin (DE)

Proteomic Forum 2015

Stock list

All quotes

TOP

  • CYTOS0.36 CHF5.88%
  • MERCK KGAA94.27 EUR2.25%
  • STRATEC BIOMEDICAL46.09 EUR1.97%

FLOP

  • VITA 345.55 EUR-3.48%
  • EVOTEC3.75 EUR-2.60%
  • MOLOGEN5.26 EUR-2.59%

TOP

  • WILEX3.15 EUR46.5%
  • EVOLVA1.67 CHF16.8%
  • BB BIOTECH270.05 EUR16.6%

FLOP

  • MOLOGEN5.26 EUR-12.3%
  • SANTHERA96.30 CHF-12.1%
  • 4SC0.78 EUR-8.2%

TOP

  • SANTHERA96.30 CHF2362.9%
  • WILEX3.15 EUR392.2%
  • FORMYCON16.23 EUR110.8%

FLOP

  • CYTOS0.36 CHF-87.3%
  • MOLOGEN5.26 EUR-55.9%
  • PAION2.12 EUR-52.0%

No liability assumed, Date: 03.03.2015

Current issue

All issues